AD
About
Atul Deshpande is the Chief Strategy Officer of Peptilogics. He previously worked at IMMEDIATE Therapeutics as a CEO and Board Member. Prior to that he was the Chief Strategy Officer at Harbour BioMed. Before joining HBM, Atul spent 7 years are Sanofi in various roles and was the Global Operations Head for Dupixent driving a successful launch for the brand globally. Atul Deshpande graduated from UC-Irvine with a doctorate in Neurobiology and Behavior and later attended Cranfield School of Management for his MBA studies.
Position in the VCSift Database
- • 85 investors hold the Chief Strategy Officer role in VCSift. Atul Deshpande is one of them.
- • 491 investors are based in Cambridge, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Cambridge, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Atul
Search Investors